News
GC Pharma Marks ‘World Hemophilia Day’
April 15, 2019 / 0 CommentsGCAM Adds New Plasma Collection Centers
November 9, 2018 / 0 CommentsCurevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate
November 9, 2018 / 0 CommentsGC Pharma Receives Korea’s MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older
October 1, 2018 / 0 CommentsGC Pharma Marks ‘World Haemophilia Day’
April 16, 2018 / 0 CommentsGreen Cross Introduces Its New Master Brand “GC”
January 2, 2018 / 0 CommentsGreen Cross Biotherapeutics inaugurates its state-of-the-art facility in Montreal
October 30, 2017 / 0 CommentsGCBT Submission to Canada’s Innovation Agenda
December 22, 2016 / 0 CommentsGreen Cross Biotherapeutics Supports Montreal Children’s Hospital Foundation
April 4, 2016 / 0 CommentsRelated Articles
GC Pharma Marks ‘World Hemophilia Day’
April 15, 2019 / 0 CommentsGCAM Adds New Plasma Collection Centers
November 9, 2018 / 0 CommentsCurevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate
November 9, 2018 / 0 CommentsGC Pharma Receives Korea’s MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older
October 1, 2018 / 0 CommentsGC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines
May 20, 2018 / 0 CommentsGC Pharma Reports Full Year 2017 Results
February 4, 2018 / 0 CommentsHave we forgotten the lessons of the tainted blood scandal?
November 28, 2017 / 0 CommentsThis post is also available in:
Français (French)